Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 5:04 pm |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
25,107 | $0.5619 | $14,108 | 478,947 (Indirect Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:47 pm |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
5,032 | $0.566 | $2,848 | 179,054 (Indirect Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:38 pm |
Athira Pharma Inc. | ATHA | Litton Mark James CEO |
4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) |
View |
| 2024-01-05 Sale |
2024-01-08 4:40 pm |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:51 pm |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
7,960 | $2.69 | $21,412 | 148,244 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-04 4:29 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
556,358 | $0 | 556,358 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:04 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
108,333 | $0 | 478,947 (Direct) |
View |
| 2024-10-03 Option Award(A) |
2024-10-03 9:50 pm |
N/A 2034-10-02 |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
325,000 | $0 | 325,000 (Direct) |
View |
| 2024-10-03 Option Award |
2024-10-03 7:07 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
650,000 | $0 | 650,000 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:47 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James President and CEO |
20,000 | $0 | 179,054 (Direct) |
View |
| 2024-02-15 Option Award |
2024-02-16 5:05 pm |
N/A 2034-02-14 |
Athira Pharma Inc. | ATHA | Litton Mark James CEO |
650,000 | $0 | 650,000 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James CEO |
20,000 | $0 | 164,086 (Direct) |
View |
| 2024-01-04 Option Award |
2024-01-08 4:40 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
20,000 | $0 | 164,086 (Direct) |
View |
| 2022-11-18 Option Award |
2023-01-31 7:33 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
662 | $2.74 | 573,906 (Direct) |
View |
| 2023-01-27 Option Award |
2023-01-31 7:33 pm |
N/A 2033-01-26 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
425,000 | $0 | 573,906 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-24 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
757 | $7.06 | 148,244 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:51 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
20,000 | $0 | 148,244 (Direct) |
View |
| 2021-11-18 Option Award |
2022-01-31 5:06 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
885 | $12.51 | 535,447 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:06 pm |
N/A 2032-01-26 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer |
400,000 | $0 | 535,447 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:05 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
50,440 | $1.35 | 235,442 (Direct) |
View |
| 2021-08-17 Exercise |
2021-08-19 5:05 pm |
N/A 2029-08-14 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
50,440 | $0 | 235,442 (Direct) |
View |
| 2021-05-18 Option Award |
2021-08-19 5:05 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
867 | $14.45 | 235,442 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:36 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
85,000 | $0 | 85,000 (Direct) |
View |
| 2020-09-22 Conversion |
2020-09-22 5:15 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
32,815 | $0 | 70,129 (Direct) |
View |
Ownership |
2020-09-17 8:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | Litton Mark James Chief Operating Officer |
0 | $0 | 281,232 (Direct) |
View |